Control of Drug Release from Microparticles by Tuning Their Crystalline Textures: A Structure–Activity Study
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Predicting drug release profiles from polymer microparticles has proven challenging due to the numerous environmental and chemical factors that affect the device and influence the rate of drug release. By measuring the various polymer properties that can influence drug release, a predictive approach can be used to select polymers with specific properties that will lead to the desired release profile for the application. To illustrate this, a library of tyrosol-derived poly(ester-arylate)s, poly(amide)s, and poly(carbonate)s were used to evaluate the effects of physical (crystallinity, water accessibility, thermal, and hydrophobicity) and chemical (polymer–drug interactions) polymer properties on the release of a highly crystalline drug dexamethasone, which was loaded at a high weight percent (wt %) in microparticles. Nuclear magnetic resonance (NMR) experiments showed that the polymer and drug were not chemically interacting and instead exist as a physical mixture even after exposure to physiological conditions. Polymer crystallinity data revealed that crystallite size was strongly correlated with faster drug release, suggesting that larger crystallites reduce the tortuosity for dexamethasone to diffuse out of the particle matrix. This correlation observed in particles with and without the drug was reproduced with bulk polymers, indicating that crystallinity data from bulk polymers can be used to predict release profiles without having to prepare drug-loaded particles. Consistent with the crystallinity data, particle pore sizes of representative formulations showed that particles with larger pores resulted in faster dexamethasone release. Interestingly, thermal properties (glass transition temperature and melting temperature), polymer hydrophobicity, and molecular weight retention at the end of the 119-day release study did not show any correlation with drug release.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This semi-crystalline/amorphous Dex form likely enhances bioavailability by enabling controlled dissolution in physiological media, unlike fully crystalline forms that may delay initial release [41].”
From Functional Surface Modification of Magnesium Implant by Drug-Loaded Biodegradable Polymer Coating (2026) · cites this paper as [41]
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
Fu, Y., & Kao, W. J. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003602259 · Cited by 1,305
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
A review of polymer dissolution
Miller-Chou, B. A., & Koenig, J. L. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00045-5 · Cited by 1,115
Higuchi equation: Derivation, applications, use and misuse
Siepmann, J., & Peppas, N. A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.051 · Cited by 1,088
Chemical shift referencing in MAS solid state NMR
Morcombe, C. R., & Zilm, K. W. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(03)00082-x · Cited by 862
Recent advances in polymeric drug delivery systems
Sung, Y. K., & Kim, S. W. (2020) · Biomaterials Research · doi:10.1186/s40824-020-00190-7 · Cited by 732
Arifin, D. Y., Lee, L. Y., & Wang, C.-H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.007 · Cited by 674
Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition
Park, T. G. (1995) · Biomaterials · doi:10.1016/0142-9612(95)93575-x · Cited by 642
Strategies to Modify the Drug Release from Pharmaceutical Systems
(2015) · Elsevier eBooks · doi:10.1016/c2014-0-02342-8 · Cited by 607
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Lengyel, M., Kállai-Szabó, N., Antal, V., Laki, A. J., & Antal, I. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030020 · Cited by 598
Wen, H., Jung, H., & Li, X. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9814-9 · Cited by 574
Drug Release from Electric-Field-Responsive Nanoparticles
Ge, J., Neofytou, E., Cahill, T. J., Beygui, R. E., & Zare, R. N. (2012) · ACS Nano · doi:10.1021/nn203430m · Cited by 534
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Giles, A. J., Hutchinson, M.-K. N. D., Sonnemann, H. M., Jung, J., Fecci, P. E., Ratnam, N. M., Zhang, W., Song, H., Bailey, R., Davis, D., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0371-5 · Cited by 492
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
Park, K., Skidmore, S., Hadar, J., Garner, J., Park, H., Otte, A., Soh, B. K., Yoon, G., Yu, D., Yun, Y., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.003 · Cited by 404
Stewart, S. A., Domínguez-Robles, J., Donnelly, R. F., & Larrañeta, E. (2018) · Polymers · doi:10.3390/polym10121379 · Cited by 390
Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
Martins, C., Sousa, F., Araújo, F., & Sarmento, B. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701035 · Cited by 362
Lee, B. K., Yun, Y., & Park, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.020 · Cited by 340
Murthy, N. S., & Minor, H. (1990) · Polymer · doi:10.1016/0032-3861(90)90243-r · Cited by 328
Self-citationBiodegradable polymers and constructs: A novel approach in drug delivery
Prajapati, S. K., Jain, A., Jain, A., & Jain, S. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.08.018 · Cited by 308
Effect of the size of biodegradable microparticles on drug release: experiment and theory
Siepmann, J., Faisant, N., Akiki, J., Richard, J., & Benoit, J. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.011 · Cited by 272
Cohesive Properties and Solubility
Van Krevelen, D. W., & Te Nijenhuis, K. (2009) · Properties of Polymers · doi:10.1016/b978-0-08-054819-7.00007-8 · Cited by 259
Evaluation of a degradable shape-memory polymer network as matrix for controlled drug release
Wischke, C., Neffe, A. T., Steuer, S., & Lendlein, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.027 · Cited by 248
pH-sensitive biomaterials for drug delivery
Zhuo, S., Zhang, F., Yu, J., Zhang, X., Yang, G., & Liu, X. (2020) · Molecules · doi:10.3390/molecules25235649 · Cited by 247
Poly(lactic acid)/poly(lactic-co-glycolic acid)-based microparticles: an overview
Blasi, P. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00453-z · Cited by 235
Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres
Jeong, J.-C., Lee, J., & Cho, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00367-5 · Cited by 209
Effect of the size of biodegradable microparticles on drug release: experiment and theory
Siepmann, J. (2004) · Journal of Controlled Release · doi:10.1016/j.conrel.2004.01.011 · Cited by 203
Kolodziejski, W., Frye, J. S., & Maciel, G. E. (1982) · Analytical Chemistry · doi:10.1021/ac00245a035 · Cited by 178
Optical Biosensors for Virus Detection: Prospects for SARS‐CoV‐2/COVID‐19
Maddali, H., Miles, C. E., Kohn, J., & O'Carroll, D. M. (2021) · ChemBioChem · doi:10.1002/cbic.202000744 · Cited by 176
Self-citationChen, Y., Liu, C., Chen, Z., Su, C., Hageman, M., Hussain, M., Haskell, R., Stefanski, K., & Qian, F. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500660m · Cited by 171
Feng, Q., Wu, J., Li, H., & Ma, G. (2018) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-018-1729-4 · Cited by 154
Hildebrand, J. H. (1916) · Journal of the American Chemical Society · doi:10.1021/ja02265a002 · Cited by 148
Izumikawa, S., Yoshioka, S., Aso, Y., & Takeda, Y. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90071-k · Cited by 136
Modelling of controlled drug release in gastrointestinal tract simulation
Permanadewi, I., Kumoro, A. C., Wardhani, D. H., & Aryanti, N. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1295/1/012063 · Cited by 134
Gasmi, H., Siepmann, F., Hamoudi, M., Danède, F., Vérin, J., Willart, J., & Siepmann, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.032 · Cited by 115
Designable Polymeric Microparticles from Droplet Microfluidics for Controlled Drug Release
He, F., Zhang, M., Wang, W., Cai, Q., Su, Y., Liu, Z., Faraj, Y., Ju, X., Xie, R., & Chu, L. (2019) · Advanced Materials Technologies · doi:10.1002/admt.201800687 · Cited by 113
Busatto, C. A., Pesoa, J., Helbling, I. M., Luna, J. A., & Estenoz, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.006 · Cited by 112
Bikiaris, D., Karavelidis, Karavas, Giliopoulos, & Papadimitriou (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26016 · Cited by 111
Lübtow, M. M., Haider, M. S., Kirsch, M., Klisch, S., & Luxenhofer, R. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00618 · Cited by 111
Non-spherical particles for targeted drug delivery
Chen, J., Clay, N. E., Park, N.-H., & Kong, H. (2014) · Chemical Engineering Science · doi:10.1016/j.ces.2014.10.022 · Cited by 101
Microparticles Used as Drug Delivery Systems
Siepmann, J., & Siepmann, F. (2006) · Springer eBooks · doi:10.1007/3-540-32702-9_3 · Cited by 99
Partial solubility parameters of poly(d,l-lactide-co-glycolide)
Schenderlein, S., Lück, M., & Müller, B. W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.034 · Cited by 98
Studies of nano-structured liquids in confined geometries and at surfaces
Webber, J. B. W. (2009) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2009.09.001 · Cited by 85
Dexamethasone-loaded poly(ε-caprolactone) intravitreal implants: A pilot study
Fialho, S. L. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.004 · Cited by 84
Obayemi, J. D., Danyuo, Y., Dozie-Nwachukwu, S. O., Odusanya, O. S., Anuku, N., Malatesta, K. A., Yu, W., Uhrich, K. E., & Soboyejo, W. O. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.04.071 · Cited by 79
A mathematical model for predicting drug release from a biodurable drug‐eluting stent coating
Hossainy, S., & Prabhu, S. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31787 · Cited by 74
Sheihet, L., Piotrowska, K., Dubin, R. A., Kohn, J., & Devore, D. I. (2007) · Biomacromolecules · doi:10.1021/bm060860t · Cited by 73
Macha, I. J., Ben‐Nissan, B., Vilchevskaya, E. N., Morozova, A. S., Abali, B. E., Müller, W. H., & Rickert, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00037 · Cited by 73
Sarmadi, M., Behrens, A. M., McHugh, K. J., Contreras, H. T. M., Tochka, Z. L., Lu, X., Langer, R., & Jaklenec, A. (2020) · Science Advances · doi:10.1126/sciadv.abb6594 · Cited by 73
Effects of drug and polymer molecular weight on drug release from PLGA ‐m PEG microspheres
Feng, S., Nie, L., Zou, P., & Suo, J. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.41431 · Cited by 58
Wu, X. S. (2004) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1081/bio-200039635 · Cited by 51
Yarce, C. J., Pineda, D., Correa, C., & Salamanca, C. H. (2016) · Pharmaceuticals · doi:10.3390/ph9030034 · Cited by 44
Stępień, K., Miles, C. E., McClain, A., Wiśniewska, E., Sobolewski, P., Kohn, J., Puskas, J. E., Wagner, H. D., & Fray, M. E. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.9b01191 · Cited by 43
Self-citationPetrov, O. V., Furó, I., Schuleit, M., Domanig, R., Plunkett, M. A., & Daicic, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.027 · Cited by 36
Arbeiter, D., Reske, T., Teske, M., Bajer, D., Senz, V., Schmitz, K., Grabow, N., & Oschatz, S. (2021) · Polymers · doi:10.3390/polym13020292 · Cited by 33
Biomedical applications of PLGA particles
Agrawal, A., Rellegadla, S., & Jain, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816913-1.00004-0 · Cited by 31
Gopinathan, N., Yang, B., Lowe, J. P., Edler, K. J., & Rigby, S. P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.018 · Cited by 30
Patel, J., Ghodbane, S. A., Brzezinski, A., Gatt, C. J., & Dunn, M. G. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517752668 · Cited by 30
Matsumoto, K., Kimura, S.-I., Itai, S., Kondo, H., & Iwao, Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.029 · Cited by 20
Structure and Thermal Transitions in a Biomedically Relevant Liquid Crystalline Poly(ester amide)
Bédoui, F., Murthy, N. S., & Kohn, J. (2017) · Macromolecules · doi:10.1021/acs.macromol.6b02473 · Cited by 14
Self-citationMiles, C. E., Lima, M. R. N., Buevich, F., Gwin, C., Murthy, N. S., & Kohn, J. (2021) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2021.109617 · Cited by 13
Self-citationTyrosol Derived Poly(ester-arylate)s for Sustained Drug Delivery from Microparticles
Miles, C. E., Gwin, C., Zubris, K. A. V., Gormley, A. J., & Kohn, J. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00448 · Cited by 10
Self-citationHansen, C. M. (2007) · CRC Press eBooks · doi:10.1201/9781420006834.ch2 · Cited by 9
Swapna, N. J., & Aukunuru, J. (2010) · Journal of Young Pharmacists · doi:10.4103/0975-1483.66792 · Cited by 8
Bioresorbable tyrosol‐derived poly(ester‐arylate)s with tunable properties
Cohen, J. P., Shultz, R. B., Mullaghy, A., Gwin, C., & Kohn, J. (2021) · Journal of Polymer Science · doi:10.1002/pol.20210047 · Cited by 7
Tyrosol-Derived Biodegradable Inks with Tunable Properties for 3D Printing
Cohen, J. P., Bektas, C. K., Mullaghy, A., Perera, M. M., Gormley, A. J., & Kohn, J. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00464 · Cited by 4
Self-citation
Cited by
Encapsulated Transition Metal Catalysts Enable Long-term Stability in Frontal Polymerization Resins
Davydovich, O., Greenlee, A. J., Root, H. D., Jansen, A. L., Gallegos, S. C., Warner, M. J., Kent, M. S., Cardenas, J. A., Appelhans, L. N., Roach, D. J., et al. (2023) · Macromolecules · doi:10.1021/acs.macromol.3c01146 · Cited by 24
Recent progress in nanomedicines for imaging and therapy of brain tumors
Hasan, I., Roy, S., Guo, B., Du, S., Tao, W., & Chang, C. (2022) · Biomaterials Science · doi:10.1039/d2bm01572b · Cited by 14
Marras-Marquez, T., Peña, J., & Veiga-Ochoa, M. D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105521 · Cited by 9
Blanco, A. F., Lou, G., Pensado‐López, A., Ummarino, A., Andón, F. T., Crecente‐Campo, J., & Alonso, M. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01942-5 · Cited by 8
“Notably, no direct correlation was found between polymer crystal-linity and release kinetics, supporting the idea that other factors—such as porosity and polymer-drug interactions— played a more dominant role [67 ].”
Lozza, I., Martín‐Sabroso, C., Hurtado, C., Montejo, C., Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125710 · Cited by 7
Metadata
- Authors
- Miles, C. E., Bernstein, A. D., Osborn Popp, T. M., Murthy, N. S., Nieuwkoop, A. J., & Gormley, A. J.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States
- Corresponding author
- Gormley, Adam J.
- Venue
- ACS Applied Polymer Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-11-19
- Volume
- 3
- Issue
- 12
- Pages
- 6548-6561
- ISSN
- 2637-6105 (ISSN-L)
- OpenAlex
- W3217614835
- Cited by
- 20
- References
- 70
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Applied Polymer Materials (publishedVersion)
- Funders
- Rutgers, The State University of New Jersey (Nieuwkoop Start-Up Grant, TechAdvance)
- Division of Chemical, Bioengineering, Environmental, and Transport Systems (2009942)
- Lubrizol Life Science
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- drug release, polymeric microparticles, crystallinity, crystallite size, dexamethasone, polycarbonate, structure-activity relationship, drug-polymer interactions, physical mixtures, pore size, glass transition temperature, melting point, hydrophobicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.